Steve Biko Academic Hospital of Pretoria, South Africa, previously located at what is now Tshwane District Hospital, is a purely tertiary training healthcare institution. It is the main teaching hospital of the University of Pretoria along with Kalafong Hospital in Atteridgeville to west of the city centre.

There are 832 beds in Pretoria Academic Hospital.

During the past decade, Pretoria Academic Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 12 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pretoria Academic Hospital" #1 sponsor was "Eastern Cooperative Oncology Group" with 27 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pretoria Academic Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Pretoria Academic Hospital" are "Head and Neck Cancer" (8 trials), "Breast Cancer" (5 trials), "Lung Cancer" (5 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Pretoria Academic Hospital" in a lesser frequency.

Most popular intervention types in "Pretoria Academic Hospital" are "Drug" (54 trials), "Biological" (12 trials), "Procedure" (11 trials), "Radiation" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (11 trials), "cisplatin" (6 trials), "fluorouracil" (6 trials), "carboplatin" (5 trials) and "cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Pretoria Academic Hospital" are 53 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Pretoria Academic Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Pretoria Academic Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pretoria Academic Hospital, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".